Andrew Hatchett

Andrew Hatchett counsels and defends clients in a wide range of high-stakes antitrust and complex commercial litigation matters. Clients count on Andrew to bring top-flight advocacy and strategy to all phases of trial and appellate litigation. He brings a seasoned perspective to his representation of pharmaceutical companies in Hatch–Waxman cases at the intersection of U.S. patent and antitrust law.

Andrew represents clients in a wide range of complex commercial litigation with an emphasis on antitrust cases in the pharmaceutical and life sciences sectors. Andrew has represented clients in cases alleging horizontal and vertical conspiracies, unilateral monopolistic conduct, and a variety of other traditional and novel antitrust theories. Andrew also has an active appellate practice, representing clients in appeals before the U.S. Supreme Court, the First, Second, Third, Sixth, Eighth, Ninth, and Eleventh Circuits, and various state appellate courts.

Andrew is active in the leadership of the American Bar Association’s (ABA) Section of Antitrust Law. He currently serves as vice chair of the Health Care and Pharmaceuticals Committee.